Innospec Inc.

NASDAQ:IOSP

Chemicals - Specialty

Basic Materials
$78.86 +0.09%

+$0.08 today

Market cap
$1.94B
Beta
0.91
P/E (TTM)
18.0
EPS (TTM)
$4.61
Dividend yield
2.15%
52W Low $65.51High $92.14

Volume 0.23M

Average 0.24M

IOSP Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Innospec Inc.NASDAQ: IOSP

Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026

Accounts receivables turns negative

Q2 FY2026 accounts receivables was -$70.2M, compared with $22.3M a year earlier. Trailing-twelve-month accounts receivables was -$91.2M.

Context

  • Accounts receivables amounted to 1.2% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Accounts receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts receivables holds near -$70.2M or moves back toward the trailing-twelve-month quarterly average of -$22.8M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$70.2M+412.4% QoQ
Last fiscal yearDec 2025
$21.6M+402.3% YoY
LTMJun 2026
-$91.2M+328.2% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-414.8%——
1 year+402.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
21.6M USD
Year-over-year change
+402.3%

Accounts Receivables vs competitors

How IOSP compares with its peers on the latest reported figures

  • IOSP's LTM Jun 2026 accounts receivables of $91.2M is the 3rd largest of the 10 companies compared; the peer median is $17.56M.
  • Its year-over-year change of +328.2% is the 2nd highest of 8, against a peer median of -98.5%.
  • Accounts receivables amounts to 5.0% of revenue for IOSP, versus a peer median of 1.5%.
IOSP Competitors Peer median
Accounts Receivables for IOSP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CLMTCalumet, Inc.LTM Sep 2026$234.6M ——4.5%
EMNEastman Chemical CompanyLTM Jun 2026$125M +635.3%-13.1%1.4%
IOSPInnospec Inc.LTM Jun 2026$91.2M +328.2%—5.0%
FULH.B. Fuller CompanyLTM Aug 2026$78.97M +316.5%-48.2%2.2%
KWRQuaker Chemical CorporationLTM Sep 2026$53.27M -696.2%—2.6%
HWKNHawkins, Inc.LTM Sep 2026$17.56M +161.8%-27.2%1.5%
NEUNewMarket CorporationLTM Jun 2026$10.65M —-47.4%0.4%
FFFutureFuel Corp.LTM Mar 2026$5.44M -129.7%+57.9%4.9%
CBTCabot CorporationLTM Jun 2026$1M -98.5%—0.0%
ASHAshland Inc.LTM Jun 2026$0 -100.0%—0.0%
Peer median (excluding IOSP) $17.56M-98.5%-27.2%1.5%

Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income93.1M133M139.1M35.6M116.6M
Depreciation & Amortization42.7M40.1M39.3M43.5M43.6M
Deferred Income Tax6.4M(5.5M)3.6M(39.3M)(10.2M)
Stock-Based Compensation4.4M6.7M8M8.5M8.1M
Change in Working Capital(48.1M)(90.1M)20.6M(18.9M)(48.4M)
Accounts Receivables(31.4M)(55.5M)(12.6M)4.3M21.6M
Inventory(62M)(98.5M)83M(11.8M)(6.6M)
Accounts Payables90.2M54.2M(26.9M)(4.5M)(32.8M)
Other Working Capital(44.9M)9.7M(22.9M)(6.9M)(30.6M)
Other Non-Cash Items(5.3M)(2.5M)(3.3M)155.1M28.6M
Operating Cash Flow93.2M81.7M207.3M184.5M138.3M
Capital Expenditures(39.1M)(42.3M)(62.1M)(41.4M)(50.3M)
Acquisitions (Net)3M2M(34.7M)(200K)(700K)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(100K)(1.8M)100K500K(24.1M)
Investing Cash Flow(36.2M)(42.1M)(111.8M)(62M)(75.1M)
Debt Repayment(600K)(100K)(2.3M)00
Common Stock Issued10.1M2.2M900K2.1M500K
Common Stock Repurchased(800K)(5.9M)(1.1M)(700K)(23.9M)
Dividends Paid(28.8M)(31.7M)(35.1M)(38.8M)(42.4M)
Other Financing Activities100K1.8M(1.4M)2.1M1.9M
Financing Cash Flow(20M)(33.7M)(39M)(35.3M)(63.9M)
Effect of Forex Changes(500K)(600K)100K(1.7M)4M
Net Change in Cash36.5M5.3M56.6M85.5M3.3M
Free Cash Flow54.1M39.4M145.2M143.1M88M

Innospec Inc.

NASDAQ:IOSP

Intrinsic Alpha fair value

Locked

Current Price

$78.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.